Metabolic obesity, adipocytokines, and inflammatory markers in Asian Indians - CURES-124

Diabetes Technology and Therapeutics

Volumn 17, Issue 2, 2015, Pages 134-141

  Indulekha, Karunakaran ^a   Surendar, Jayagopi ^a   Anjana, Ranjit Mohan ^a   Geetha, Loganathan ^a   Gokulakrishnan, Kuppan ^a   Pradeepa, Rajendra ^a   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDIZED LOW DENSITY LIPOPROTEIN; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; ARTICLE; ASIAN; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; GENETICS; IMMUNOLOGY; INDIA; INFLAMMATION; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; STATISTICAL MODEL;

BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIA; INFLAMMATION; INTERLEUKIN-6; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PREVALENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922452629     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0202     Document Type: Article

References (32)

1. Coppack SW: Adipose tissue changes in obesity. Biochem Soc Trans 2005;33:1049-1052.
2. Wildman RP, Muntner P, Reynolds K, et al.: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168:1617-1624.
3. Blüher M: The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21: 38-43.
4. Geetha L, Deepa M, Anjana RM, et al.: Prevalence and clinical profile of metabolic obesity and phenotypic obesity in Asian Indians. J Diabetes Sci Technol 2011;5:439-446.
5. Sharp PS, Mohan V, Levy JC, et al.: Insulin resistance in patients of Asian Indian and European origin with noninsulin dependent diabetes. Horm Metab Res 1987;19: 84-85.
6. Hajer GR, van Haeften TW, Visseren FL: Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959-2971.
7. Deepa M, Pradeepa R, Rema M, et al.: The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003;51:863-870.
8. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1992;18:499-502.
9. Heng D, Ma S, Lee JJM, et al.: Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis 2006;186:367-373.
10. Enas EA, Mohan V, Deepa M, et al.: The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr 2007;2:267-275.
11. Deepa S, Farooq M, Datta M, et al. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians-the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007;23: 127-134.
12. Karelis AD, St-Pierre DH, Conus F, et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
13. Raji A, Seely EW, Arky RA, et al.: Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001;86:5366-5371.
14. Hyun YJ, Koh SJ, Chae JS, et al.: Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity (Silver Spring) 2008;16: 784-789.
15. Koerner A, Kratzsch J, Kiess W: Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005;19:525-546.
16. Sonoli SS, Shivprasad S, Prasad CV, et al.: Visfatin-a review. Eur Rev Med Pharmacol Sci 2011;15:9-14.
17. Choi KM, Lee J, Lee KW, et al.: Comparison of serum concentrations of C-reactive protein, TNF-α, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract 2004; 64:99-106.
18. Cathcart MK, Morel DW, Chisolm GM: Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol 1985;38:341-350.
19. Gómez-Ambrosi J, Catalán V, Rodríguez A, et al.: Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care 2014;37:2813-2821.
20. Tilg H, Wolf AM: Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 2005;9: 245-251.
21. Kim KY, Kim JK, Jeon JH, et al.: c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-α in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2005;327:460-467.
22. Liu S, Yin T, Wei X, et al.: Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury. Crit Care Med 2011;39:1935-1943.
23. Yang X, Jansson PA, Pellmé F, et al.: Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity. Obes Res 2005;13:813-817.
24. Kamimura D, Ishihara K, Hirano T: IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003;149:1-38.
25. Ouyang F, Necheles J, Wang B, et al.: Association of surrogate and direct measures of adiposity with risk of metabolic syndrome in rural Chinese women. Eur J Nutr 2009;48:323-32.
26. Yanagisawa K: The effects of body fat distribution on glucose tolerance in overweight subjects: glucose intolerance and insulin resistance induced by intra-abdominal fat accumulation [in Japanese]. Nihon Naibunpi Gakkai Zasshi 1991;67:1240-1251.
27. Simons PJ, van den Pangaart PS, Aerts JM, et al.: Proinflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol 2007;192:289-299.
28. Krishnaswamy G, Kelley J, Yerra L, et al.: Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 1999;19:91-104.
29. Ye J: Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 2009;33:54-66.
30. Katsuki A, Suematsu M, Gabazza EC, et al.: Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 2006;73:310-314.
31. Jin H, Jiang B, Tang J, et al.: Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res Clin Pract 2008;79:412-418.
32. Lee DE, Kehlenbrink S, Lee H, et al.: Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 2009;296:E1210-E1229.